Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leon A Adams

Showing results (61-70 of 203) with videos related to

Pageof 21
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2008
Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasiaAndrew Mitchell, Leon A Adams, Gerry MacQuillan, et al.
Advances in Nutrition (Bethesda, Md.)|January 17, 2016
Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial GenesJill L Sherriff, Therese A O'Sullivan, Catherine Properzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 4, 2012
The Framingham risk score and heart disease in nonalcoholic fatty liver diseaseSombat Treeprasertsuk, Scott Leverage, Leon A Adams, et al.
The American Journal of Gastroenterology|March 19, 2009
NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up studyLeon A Adams, Oliver R Waters, Matthew W Knuiman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 20, 2018
Hepatocellular carcinoma in Australia 1982-2014: Increasing incidence and improving survivalMichael C Wallace, David B Preen, Mark W Short, et al.
The Medical Journal of Australia|September 2, 2016
Reversal of end-stage renal failure using direct-acting antiviral agents for chronic hepatitis CTim Mitchell, Aron Chakera, Gary P Jeffrey, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 16, 2025
Clonal hematopoiesis of indeterminate potential: a unifying mechanism linking metainflammation and cardiometabolic diseasesNethma Savindi Wimalarathne, Nick S R Lan, Jacob George, et al.
Nutrients|June 28, 2023
Higher Overall Intakes Are the Defining Feature of Dietary Intakes in NAFLD and Compared to the General PopulationCatherine Properzi, Leon A Adams, Johnny Lo, et al.
Nature Reviews. Gastroenterology & Hepatology|May 31, 2018
Noninvasive biomarkers in NAFLD and NASH - current progress and future promiseVincent Wai-Sun Wong, Leon A Adams, Victor de Lédinghen, et al.
Clinical Chemistry and Laboratory Medicine|November 16, 2012
High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosisEnrico Rossi, Leon A Adams, Helena L Ching, et al.
Pageof 21

Showing results (61-70 of 203) with videos related to

Sort By:
Pageof 21
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2008
Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasiaAndrew Mitchell, Leon A Adams, Gerry MacQuillan, et al.
Advances in Nutrition (Bethesda, Md.)|January 17, 2016
Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial GenesJill L Sherriff, Therese A O'Sullivan, Catherine Properzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 4, 2012
The Framingham risk score and heart disease in nonalcoholic fatty liver diseaseSombat Treeprasertsuk, Scott Leverage, Leon A Adams, et al.
The American Journal of Gastroenterology|March 19, 2009
NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up studyLeon A Adams, Oliver R Waters, Matthew W Knuiman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 20, 2018
Hepatocellular carcinoma in Australia 1982-2014: Increasing incidence and improving survivalMichael C Wallace, David B Preen, Mark W Short, et al.
The Medical Journal of Australia|September 2, 2016
Reversal of end-stage renal failure using direct-acting antiviral agents for chronic hepatitis CTim Mitchell, Aron Chakera, Gary P Jeffrey, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 16, 2025
Clonal hematopoiesis of indeterminate potential: a unifying mechanism linking metainflammation and cardiometabolic diseasesNethma Savindi Wimalarathne, Nick S R Lan, Jacob George, et al.
Nutrients|June 28, 2023
Higher Overall Intakes Are the Defining Feature of Dietary Intakes in NAFLD and Compared to the General PopulationCatherine Properzi, Leon A Adams, Johnny Lo, et al.
Nature Reviews. Gastroenterology & Hepatology|May 31, 2018
Noninvasive biomarkers in NAFLD and NASH - current progress and future promiseVincent Wai-Sun Wong, Leon A Adams, Victor de Lédinghen, et al.
Clinical Chemistry and Laboratory Medicine|November 16, 2012
High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosisEnrico Rossi, Leon A Adams, Helena L Ching, et al.
Pageof 21